Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Qingrexuanfei Plaster is a Traditional Chinese Medicine (TCM) topical formulation developed by The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine for pediatric respiratory conditions. It is primarily indicated for the treatment of community-acquired pneumonia and acute bronchitis (specifically rheumatic pulmonary syndrome) in children. The plaster is applied externally, typically to the chest or back, to facilitate the transdermal absorption of herbal constituents intended to clear heat and ventilate the lungs. In clinical practice, it is often used as an adjuvant therapy alongside conventional Western medical treatments to improve clinical outcomes, such as accelerating the disappearance of lung rales and enhancing the overall quality of life for pediatric patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiao'er Qingrexuanfei Plaster.